Stock Screener App

Gratuito - Play StoreApp Store

Installare Installare

NRIX

$15.0941.56%-10.73

Dopo l'orario di chiusura: 17.40+2.31 +15.31%

Nurix Therapeutics Inc (NRIX)

Date: O: H: L: C: Vol:

Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie

Officer Christine Ring proposes selling 10,602 Nurix Therapeutics (NRIX) shares. - Stock Titan

Xencor, Inc. (XE9.F) Seasonal Returns Chart - Yahoo! Finance Canada

Nurix Therapeutics stock: Roche deal lifts Q3 revenue to USD 673.1m - ad-hoc-news.de

Roche's 9M 2026 Sales Rise on Strong Drug Demand, Pipeline Advances - Zacks Investment Research

Can KYMR's Targeted Protein Degradation Pipeline Drive Future Growth? - Zacks Investment Research

ABCL News | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL) - ChartMill

Form 4 Nurix Therapeutics Inc: Gwenn Hansen (Chief Scientific Officer) For: 15 October By Investing.com - Investing.com South Africa

Nurix Therapeutics CSO Gwenn Hansen sells $36,300 in common stock - Investing.com

Nurix Therapeutics CSO Gwenn Hansen sells $36,300 in common stock By Investing.com - Investing.com Nigeria

Nurix director Gregory sells $528,528 in stock following option exercise By Investing.com - Investing.com UK

Nurix director Gregory sells $528,528 in stock following option exercise By Investing.com - Investing.com Nigeria

Form 4 Nurix Therapeutics Inc: Julia P. Gregory (Director) For: 14 October - Investing.com India

Nurix director Gregory sells $528,528 in stock following option exercise - Investing.com

Form 4 Nurix Therapeutics Inc: Julia P. Gregory (Director) For: 14 October - Investing.com Nigeria

Form 4 Nurix Therapeutics Inc: Julia P. Gregory (Director) For: 14 October - Investing.com Canada

Form 4 Nurix Therapeutics Inc: Julia P. Gregory (Director) For: 14 October - Investing.com UK

Nurix director Gregory sells $528,528 in stock following option exercise By Investing.com - Investing.com Canada

Nurix Therapeutics Director Sold Shares Worth Over $528K - TradingView

Nurix Therapeutics Insider Sold Shares Worth $528,528, According to a Recent SEC Filing - Yahoo Finance

A director proposes selling 22,583 Nurix Therapeutics (Nasdaq: NRIX) shares acquired by exercising options. - Stock Titan

A director exercises $1.86 options, then sells 22,583 Nurix Therapeutics (NRIX) shares. - Stock Titan

Form 4 Nurix Therapeutics Inc: Christine Ring (CLO) For: 2 October - Investing.com Australia

U.S. Analyst Updates: October 13th, 2026 - The Globe and Mail

Nurix Therapeutics CLO sells $134k in stock after option exercise - Investing.com

Form 4 Nurix Therapeutics Inc: Christine Ring (CLO) For: 2 October - Investing.com Canada

Form 4 Nurix Therapeutics Inc: Christine Ring (CLO) For: 2 October - Investing.com Nigeria

Form 4 Nurix Therapeutics Inc: Christine Ring (CLO) For: 2 October - Investing.com UK

Nurix Therapeutics CLO sells $134k in stock after option exercise - Investing.com UK

Nurix Therapeutics, Inc. (NRIX) Q3 Earnings and Revenues Surpass Estimates - Zacks Investment Research

Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update - Yahoo Finance

The first patient has joined a trial testing two drugs for a type of blood cancer. - Stock Titan

Trade Figures, Fed in Picture This Week - baystreet.ca

An officer proposes selling 5,786 shares of Nurix Therapeutics (NRIX). - Stock Titan

Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock? - Zacks Investment Research

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Stock Has Consensus Price Target of $34.21 According to Analysts - MarketBeat

842,089 Shares in Nurix Therapeutics, Inc. $NRIX Bought by Bank of America Corp DE - MarketBeat

More than 5% of Nurix Therapeutics (NRIX) is reported by three parties, but one fund holds the shares. - Stock Titan

AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates - Zacks Investment Research

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: A Biotech Gem With A 33% Upside Potential - DirectorsTalk Interviews

AMC Global Media Inc. - Class A Common Stock (NQ: AMCX - The Chronicle-Journal

Behavioral Patterns of NRIX and Institutional Flows - Stock Traders Daily

We Think Nurix Therapeutics (NASDAQ:NRIX) Can Afford To Drive Business Growth - Moomoo

Nurix Therapeutics, Inc. (NRIX) Latest Stock News & Headlines - Yahoo Finance

Here's Why You Should Add NRIX Stock to Your Portfolio Now - Yahoo Finance

Transcript : Nurix Therapeutics, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-08-2026 03 - marketscreener.com

Nurix Therapeutics (NRIX) Upgraded to Buy: Here's Why - Yahoo Finance

Nurix Therapeutics at Wells Fargo conference: pipeline, deal momentum By Investing.com - Investing.com India

Nurix Therapeutics at Wells Fargo conference: pipeline, deal momentum - investing.com

Legal & General Group Plc Buys Shares of 72,026 Nurix Therapeutics, Inc. $NRIX - MarketBeat

Nurix Therapeutics Stock Price Forecast. Should You Buy NRIX? - StockInvest.us

Simile a NRIX

ADRX$15.473.85%

KLRA$12.460.99%

RARE$17.092.77%

NVAX$10.265.94%

NTLA$12.132.28%